导管市场 - 全球产业规模、份额、趋势、机会和预测，按产品类型、最终用途、地区和竞争细分，2020-2030 年

2024 年全球导管市场价值为 584.5 亿美元，预计到 2030 年将达到 802.7 亿美元，预测期内的年复合成长率(CAGR) 为 5.39%。近年来，由于慢性病发病率不断上升、全球人口老化以及医疗技术的进步，市场经历了显着增长。导管是用于各种应用的重要医疗设备，包括心血管、泌尿科、神经血管和静脉手术。它们在医院、门诊手术中心和家庭医疗保健机构的广泛使用促进了这种扩展。此外，人们对微创手术的认识不断提高，加速了对创新导管技术的需求。

推动导管市场成长的一个主要因素是心血管疾病（CVD）和泌尿系统疾病发生率的上升。心血管导管，例如血管摄影导管和电生理导管，广泛用于心臟病的诊断和治疗。同样，导尿管对于患有尿失禁和其他膀胱相关问题的患者（尤其是老年患者）来说是必不可少的。慢性病发生率不断上升，加上外科手术数量的不断增加，预计将维持对导管的需求。

导管设计和材料的技术进步是扩大市场的关键。抗菌涂层和药物洗脱导管的发展大大降低了与导管插入相关的感染风险。此外，配备即时监控感测器的智慧导管的出现提高了患者的安全性和治疗效果。製造商也专注于生物相容性材料，以增强导管的耐用性和性能，使其更适合患者。

主要市场驱动因素

慢性病盛行率上升

住院和手术次数增加

主要市场挑战

定价压力和报销问题

供应链中断和材料短缺

主要市场趋势

技术进步

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：COVID-19 对全球导管市场的影响

第五章：全球导管市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型（心血管导管（电生理导管、PTCA 球囊导管、IVUS 导管、PTA 球囊导管）、泌尿科导管（血液透析导管、腹膜导管、Foley 导管、间歇导管、外部导管）、静脉导管（外周导管、中线外周导管、中心静脉导管）、神经血管导管（特种导管、伤口/手术导管、血导管、热导管
  • 依最终用途（医院商店、零售店、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美导管市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 墨西哥
  • 加拿大

第 7 章：欧洲导管市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 西班牙

第 8 章：亚太导管市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 韩国
  • 日本
  • 澳洲

第 9 章：南美导管市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲导管市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如果有）
• 最新动态

第 13 章：全球导管市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Hollister Incorporated
• Medtronic PLC
• Boston Scientific Corporation
• Edward Lifesciences
• Smith Medical Inc.
• Teleflex Incorporated
• ConvaTec Group Plc
• Cure Medical LLC
• Terumo Corporation
• Cook Medical Inc.

第 16 章：策略建议

第17章 调査会社について・免责事项

The global catheter market was valued at USD 58.45 billion in 2024 and is projected to reach USD 80.27 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.39% during the forecast period. The market has experienced significant growth in recent years, driven by the increasing prevalence of chronic diseases, an aging global population, and advancements in medical technology. Catheters are vital medical devices used in a variety of applications, including cardiovascular, urology, neurovascular, and intravenous procedures. Their widespread use across hospitals, ambulatory surgical centers, and home healthcare settings has contributed to this expansion. Furthermore, rising awareness of minimally invasive procedures has accelerated demand for innovative catheter technologies.

A major factor driving growth in the catheter market is the rising incidence of cardiovascular diseases (CVDs) and urinary disorders. Cardiovascular catheters, such as angiography and electrophysiology catheters, are widely used in the diagnosis and treatment of heart conditions. Similarly, urinary catheters are essential for patients with urinary incontinence and other bladder-related issues, particularly in the elderly. The increasing prevalence of chronic diseases, coupled with the rising number of surgical procedures, is expected to sustain the demand for catheters.

Technological advancements in catheter design and materials have been key in expanding the market. The development of antimicrobial-coated and drug-eluting catheters has significantly reduced infection risks associated with catheterization. Additionally, the emergence of smart catheters, equipped with sensors for real-time monitoring, has improved patient safety and treatment outcomes. Manufacturers are also focusing on biocompatible materials to enhance the durability and performance of catheters, making them more patient-friendly.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global catheter market is experiencing strong growth, largely driven by the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, urinary incontinence, and neurological conditions. These diseases often require continuous treatment, surgical procedures, and hospital care, with catheters playing a crucial role in patient management. Additionally, the growing geriatric population, technological advancements in catheter design, and the expansion of healthcare infrastructure worldwide have further increased demand for these devices.

Cardiovascular diseases (CVDs) are a leading cause of death globally, with conditions such as coronary artery disease, heart failure, and arrhythmias requiring catheter-based interventions. According to the World Health Organization (WHO), CVDs cause approximately 17.9 million deaths annually, underscoring the need for advanced cardiac treatments. Catheters are crucial in procedures such as angioplasty, electrophysiology studies, and cardiac catheterization. As minimally invasive techniques gain popularity, the demand for advanced cardiovascular catheters, including balloon catheters, electrophysiology catheters, and guiding catheters, has increased. The growing number of catheter-based cardiac ablation procedures to treat atrial fibrillation further boosts market demand. Moreover, innovations like steerable catheters and bioresorbable stents have enhanced the efficacy of catheter-based cardiac interventions.

Diabetes is another significant driver of catheter demand, as the condition is associated with various complications, such as kidney disease, neuropathy, and urinary retention, which often require catheter interventions. The International Diabetes Federation (IDF) estimates that over 537 million adults were living with diabetes in 2021, with the number expected to reach 783 million by 2045. For diabetic patients with end-stage renal disease (ESRD), hemodialysis is a critical treatment, requiring the use of tunneled and non-tunneled dialysis catheters. Furthermore, insulin pump therapy, which uses catheter-based infusion sets, is becoming more popular for better glycemic control, contributing to market growth.

Urinary incontinence and other bladder disorders are increasingly common, particularly among the aging population. Conditions such as benign prostatic hyperplasia (BPH), neurogenic bladder, and spinal cord injuries often necessitate catheterization for urine drainage. Foley catheters, intermittent catheters, and external catheters are commonly used for managing urinary retention and incontinence. The aging population is a major factor driving the growing demand for urinary catheters. According to the United Nations, the number of individuals aged 65 and older is expected to double by 2050, reaching 1.5 billion. As age-related urological disorders become more prevalent, the need for long-term catheter use in home healthcare settings is increasing. Additionally, the rising acceptance of self-catheterization for greater patient independence is accelerating market growth.

Increasing Hospitalizations and Surgical Procedures

The global catheter market is also expanding due to the rising number of hospitalizations and surgical procedures. Catheters are essential medical devices used in numerous diagnostic and therapeutic applications, making them indispensable in modern healthcare. The growing prevalence of chronic diseases, combined with advancements in medical technology, has significantly increased catheter demand. As healthcare providers aim to improve patient outcomes and minimize complications, the catheter market is set for continued growth.

The World Health Organization (WHO) reports that millions of people undergo surgical procedures annually, with surgery contributing to approximately 13% of global disability-adjusted life years (DALYs). An important driver of market growth is the increasing number of surgical interventions across various medical specialties. CVDs, a leading cause of global mortality, often require frequent catheter-based medical interventions. Procedures such as angioplasty, stent placement, and electrophysiology studies rely heavily on the use of cardiovascular catheters. The increasing incidence of heart diseases, driven by factors like aging populations, sedentary lifestyles, and poor dietary habits, has led to a higher number of cardiac surgeries and catheter-based treatments.

Key Market Challenges

Pricing Pressure and Reimbursement Issues

The catheter market is highly competitive, resulting in significant pricing pressures among manufacturers. Healthcare providers and governments, especially in cost-sensitive regions, are demanding lower prices for medical devices, which erodes profit margins for companies. Furthermore, reimbursement policies vary across countries, impacting the affordability of catheters for patients. In some regions, limited insurance coverage or restrictive reimbursement policies may reduce accessibility to advanced catheter technologies, hindering market growth.

Supply Chain Disruptions and Material Shortages

The global supply chain for medical devices, including catheters, has been significantly disrupted by geopolitical tensions, trade restrictions, and logistical bottlenecks. The COVID-19 pandemic exposed vulnerabilities in supply chains, leading to shortages of essential raw materials such as silicone, latex, and polyurethane, which are critical in catheter manufacturing. These disruptions have resulted in increased production costs and delays in product availability, affecting both manufacturers and healthcare providers.

Key Market Trends

Technological Advancements

The catheter market is experiencing substantial growth driven by rapid technological innovations. Advances in catheter materials, design, and functionality are enhancing patient comfort, reducing infection risks, and improving overall procedural efficiency. Key innovations include the development of antimicrobial coatings, hydrophilic surface modifications, and the use of biocompatible materials like silicone and polyurethane, which have improved flexibility, durability, and compatibility with the human body. These advancements make catheters more effective and patient-friendly, further driving market expansion.

Key Market Players

• Hollister Incorporated
• Medtronic PLC
• Boston Scientific Corporation
• Edwards Lifesciences
• Smith Medical Inc.
• Teleflex Incorporated
• ConvaTec Group Plc
• Cure Medical LLC
• Terumo Corporation
• Cook Medical Inc.

Report Scope

This report provides a detailed analysis of the global catheter market, segmented into the following categories:

• Product Type: Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, Specialty Catheters.
• End-Use: Hospital Stores, Retail Stores, Others.
• Region: North America (United States, Canada, Mexico), Europe (France, United Kingdom, Italy, Germany, Spain), Asia Pacific (China, India, Japan, Australia, South Korea), South America (Brazil, Argentina, Colombia), Middle East & Africa (South Africa, Saudi Arabia, UAE).

Competitive Landscape

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Catheter Market

5. Global Catheter Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Cardiovascular Catheters( Electrophysiology Catheters, PTCA Balloon Catheters, IVUS Catheters, PTA Balloon Catheters), Urology Catheters (Hemodialysis Catheters, Peritoneal Catheters, Foley Catheters, Intermittent Catheters, External Catheters), Intravenous Catheters( Peripheral Catheters, Midline Peripheral Catheters, Central Venous Catheters), Neurovascular Catheters (Specialty Catheters, Wound/Surgical Catheters, Oximetry Catheters, Thermodilution Catheters, IUI Catheters)
  • 5.2.2. By End Use (Hospital Stores, Retail Stores, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Catheter Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Catheter Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Catheter Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Catheter Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End Use

7. Europe Catheter Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Catheter Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Catheter Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Catheter Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Catheter Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Catheter Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End Use

8. Asia Pacific Catheter Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Catheter Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Catheter Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Catheter Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Catheter Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Catheter Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By End Use

9. South America Catheter Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Catheter Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Catheter Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Catheter Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Catheter Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Catheter Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Catheter Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Catheter Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Catheter Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Hollister Incorporated
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Medtronic PLC
• 15.3. Boston Scientific Corporation
• 15.4. Edward Lifesciences
• 15.5. Smith Medical Inc.
• 15.6. Teleflex Incorporated
• 15.7. ConvaTec Group Plc
• 15.8. Cure Medical LLC
• 15.9. Terumo Corporation
• 15.10. Cook Medical Inc.

16. Strategic Recommendations

17. About Us & Disclaimer